Company news

Fosun International Limited news in 2025

Fosun International Limited's news releases, calls and decks from 2025, newest first.

View company

Fosun International Honored as “ESG Leading Enterprise” by Bloomberg Businessweek/Chinese Edition

November 21, 2025

Fosun International: Henlius Completes Patient Enrolment in the U.S. Bridging Study of Serplulimab in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

October 23, 2025

Fosun International Signs Strategic Cooperation Agreement with BNP Paribas

October 13, 2025

S&P Global CSA Score Rises to 72, Retains Industry Lead

October 9, 2025

Fosun International Achieves AA- in HSI ESG Rating for Third Consecutive Year, Marks Sixth Year as Constituent of Hang Seng Corporate Sustainability Benchmark Index

September 14, 2025

Holds Signing Ceremony for USD910 Million Equivalent Syndicated Loan, Underscoring Global Market Confidence in its Future Development

September 10, 2025

Pharma Gains Exclusive Rights for Accro's Novel Small-Molecule Drug Candidate AC-201 in Greater China

September 1, 2025

Fosun International: Hosts 2025 Interim Results Presentation, Reaffirms Confidence in Future Development Driven by Innovation and Globalization

August 29, 2025

Decks in 2025